These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 15876205

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Model-averaged benchmark concentration estimates for continuous response data arising from epidemiological studies.
    Noble RB, Bailer AJ, Park R.
    Risk Anal; 2009 Apr; 29(4):558-64. PubMed ID: 19144062
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR, Sweeney LM, Teta MJ, Sielken RL, Valdez-Flores C, Albertini RJ, Gargas ML.
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [Abstract] [Full Text] [Related]

  • 8. Properties of model-averaged BMDLs: a study of model averaging in dichotomous response risk estimation.
    Wheeler MW, Bailer AJ.
    Risk Anal; 2007 Jun; 27(3):659-70. PubMed ID: 17640214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A probabilistic framework for non-cancer risk assessment.
    Chen JJ, Moon H, Kodell RL.
    Regul Toxicol Pharmacol; 2007 Jun; 48(1):45-50. PubMed ID: 17166641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bayesian ranking of sites for engineering safety improvements: decision parameter, treatability concept, statistical criterion, and spatial dependence.
    Miaou SP, Song JJ.
    Accid Anal Prev; 2005 Jul; 37(4):699-720. PubMed ID: 15949462
    [Abstract] [Full Text] [Related]

  • 18. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
    Kuljus K, von Rosen D, Sand S, Victorin K.
    Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L, Gocke E, Lavé T, Pfister T.
    Toxicol Lett; 2009 Nov 12; 190(3):317-29. PubMed ID: 19443141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.